retatrutide weight loss clinical trials retatrutide Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage trial, the company announced. In Retatrutide Results: 24% Weight Loss

Despite likely being a similar tier as GLP-1 RAs and SGLT2is for many patient insurances, this elevated AWP is important to note for patients with co-insurances, deductibles, the Medicare coverage gap, patients without insurance, and for the total cost of healthcare

But with a lot of attention comes a lot of misinformation, misunderstandings, and concerns

And if youve been working on your nutrition, showing up to your workouts, prioritizing protein, trying to be consistent, it can start to feel like youre doing all of the right things, but moving much more slowly and it can feel like youre behind

And oral small-molecule agents have a lot of advantages

Distribute across meals for optimal utilization